New Delhi: The deaths of at least 23 children in Madhya Pradesh after consuming adulterated cough syrup renewed scrutiny of Tamil Nadu’s drug testing failures.

A performance audit by the Comptroller and Auditor General of India (CAG), accessed by The Indian Express, exposes years of missed inspections, inadequate sampling, and manpower shortages in the state’s drug control system. The cough syrup, Coldrif, was produced by Tamil Nadu-based Sresan Pharmaceuticals, whose owner has since been arrested. Read Also MP Cough Syrup Case: Death Toll Reaches 22 As Two More Children Die During Treatment; Owner Of...

CAG Flags Systemic Gaps in Tamil Nadu’s Drug Oversight

The CAG audit, which reviewed public health infrastructure between 2016 and 2022, revealed that Tamil Nadu’s drug inspectors

See Full Page